BioPharma Investments ranging from Biotech, Pharmaceutical, & Medical Device. Stocks in the Healthcare Sector. BioPharma Run-up Principles Based on Clinical Trial Recommendations by the FDA. Stocks Based on Science not Hype.
Like it Owner: 
statefan3778
Listed in: Business
Language: English
Tags: Stocks, Biotech, Pharmaceutical, Investing, Investments
Site Statistics
Unique Visitors Today:
0
Page Views Today:
0
Unique Visitors this Week:
0
Page Views this Week:
0
Unique Visitors this Month:
9
Page Views this Month:
11
Total Unique Visitors:
27,631
Total Page Views:
37,500
Total Hits Out:
177
Latest Blog Posts for Biopharma Investor
- Antares Pharma: $ATRS A Risky BuyAntares Pharmaceuticals is a Hot Biopharma Investment Right Now So let's start off with Antares Pharma. Most of my previous stocks that I have written about have done very well in the past few years so I'll continue with that trend with this s...
- Sarepta Therapeutics: What Now After FDA Delay?With the recent FDA delay, what's the deal with Sarepta Therapeutics. Seems like a sure thing but then why would the FDA delay their decision and request more data. A good look at their clinical trail is in the WSJ this week. Where's the drug F...
- Links for 2016-04-29 [del.icio.us]on Apr 30, 2016Sponsored: 64% off Code Black Drone with HD Camera Our #1 Best-Selling Drone--Meet the Dark Night of the Sky!
- Biopharma Investor Further Development - Stock TradingSo it's been a minute. I went back to school for Programming and Database Technologies. I will be able to fulfill some programming and back end work for App Development and further Stock Analysis on Biotech and Pharmaceuticals. I have finally g...
- 4 Best Biopharma Stock Trades 2013Below are some of the best trades in the Biopharma Stock Sector since January 2013. I have gathered my research from a pretty good stock investment forum, 4-Trader. It's all free. I would never ask you to pay for anything on my site. No catches...
- Antares Pharma: $ATRS A Risky Buy That Might Actually Pay OffAntares Pharmaceuticals is a Hot Biopharma Investment Right Now I'm getting back into action here with BioPharma Investor. There is a lot of work I need to do to fix this website and upgrade it as it should be better, but on that note... So l...
- Biopharma Investoron May 20, 2013 in biopharma investorWe are working on creating a new feature and design for BioPharma Investor here soon. Hopefully a better website and more update content. Thanks for your patience while I get this up and running. Web Design and Database Programming doesn't happ...
- The future of Biopharma Investoron Apr 16, 2012 in biopharma investorSo I'm in school right now to become a web designer and haven't had much time to keep up with BioPharma Investor on blogger. I apologize, but will be creating a Biopharmainvestor.com at some point in time with lots of features and mobile apps(event...
- 60 Minutes on J. Craig Venter: Designing LifeImage via WikipediaJ. Craig Venter: Designing Life June 12, 2011 5:00 PM Steve Kroft profiles famous microbiologist J. Craig Venter, whose scientists have already mapped the human genome and created what he calls "the first synthetic species.
- Cancer Clinical Trials and Treatments Late Stage DevelopmentsImage via WikipediaFrom FierceBiotech For the cancer drug research enthusiast, this report might read in places like a special oncology edition of a gun magazine. Indeed, there are plenty of weapons against cancer to read about here. Several of t...
Loading Comments...
Comments
{ds_PageTotalItemCount} commentcomments
{pvComments::date}
{pvComments::comment}
